Product
QLS-111
Aliases
Experimental: QLS-111 ophthalmic solution, (0.015%), Experimental: QLS-111 ophthalmic solution, (0.03%), Experimental: QLS-111 ophthalmic solution, (0.075%), QLS-111 ophthalmic solution, (0.015%) (1 other aliases)
3 clinical trials
8 indications
Indication
Eye conditions unspecifiedIndication
Ocular HypertensionIndication
Primary Open Angle GlaucomaIndication
Primary Open Angle Glaucoma of Both EyesIndication
Primary Open-Angle GlaucomaIndication
GlaucomaIndication
Normal-Tension GlaucomaIndication
BilateralClinical trial
A Randomized, Multi-site, Double-masked Study Evaluating the Safety and Tolerability of QLS-111 vs Vehicle in Primary Open-angle Glaucoma or Ocular Hypertension PatientsStatus: Recruiting, Estimated PCD: 2024-09-05
Clinical trial
A Randomized, Vehicle-controlled, Double-masked Study to Evaluate the Safety and Tolerability of QLS-111 Versus Vehicle in Subjects With Normal Tension Glaucoma (NTG)Status: Not yet recruiting, Estimated PCD: 2025-02-17
Clinical trial
A Pilot, Double-masked, Vehicle-controlled, Randomized Study to Evaluate the Safety and Tolerability of QLS-111 Versus Vehicle in Combination With Latanoprost Treatment in Subjects With Open-angle Glaucoma and/or Ocular HypertensionStatus: Recruiting, Estimated PCD: 2024-10-05